Lung Cancer | Establishment of a PDT Patient Registry

Lung Cancer research study

What is the primary objective of this study?

This is a non-intervention patient registry to gather data on the use of photodynamic therapy under real-life conditions. It will involve up to 20 sites in USA.

Who is eligible to participate?

Inclusion Criteria: - All adult patients (≥ 18 years of age) treated with PDT. - Women and men and members of all races and ethnic groups. - Subjects may have received prior treatment for their cancer. - Subjects to give a written informed consent for prospectively collected data. Exclusion Criteria: - Subjects participating in any interventional studies.

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Lung Cancer

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Other:No interventionThere are no interventions associated with this registry as it is purely observational.

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Study Status

Not yet recruiting

Start Date: July 15, 2018

Completed Date: December 15, 2023


Type: Observational [Patient Registry]


Primary Outcome: PDT Outcome

Secondary Outcome:

Study sponsors, principal investigator, and references

Principal Investigator: Sandra Gollnick, Ph.D.

Lead Sponsor: Concordia Laboratories Inc.

Collaborator: Roswell Park Cancer Institute

More information: